DKK405.00
0.40% today
Copenhagen, Sep 02, 11:13 am CET
ISIN
DK0060336014
Symbol
NSIS B
Sector
Industry

Novonesis Stock price

DKK403.40
-17.40 4.14% 1M
-35.30 8.05% 6M
-4.30 1.05% YTD
-64.60 13.80% 1Y
-11.50 2.77% 3Y
+36.00 9.80% 5Y
+117.60 41.15% 10Y
+340.40 540.32% 20Y
Copenhagen, Closing price Mon, Sep 01 2025
-2.20 0.54%
ISIN
DK0060336014
Symbol
NSIS B
Sector
Industry

Key metrics

Basic
Market capitalization
DKK189.1b
Enterprise Value
DKK211.1b
Net debt
DKK22.1b
Cash
DKK2.7b
Shares outstanding
465.6m
Valuation (TTM | estimate)
P/E
44.6 | 28.7
P/S
6.2 | 6.0
EV/Sales
6.9 | 6.7
EV/FCF
49.7
P/B
2.4
Dividends
DPS
DKK6.20
Yield 1Y | 5Y
1.5% | 1.5%
Growth 1Y | 5Y
0.0% | 3.4%
Payout 1Y | 3Y
124.8% | 63.4%
Increased
0 Years
Financials (TTM | estimate)
Revenue
DKK30.6b | DKK31.6b
EBITDA
- | DKK12.0b
EBIT
DKK6.9b | DKK8.4b
Net Income
DKK4.2b | DKK6.5b
Free Cash Flow
DKK4.2b
Growth (TTM | estimate)
Revenue
34.5% | 10.5%
EBITDA
- | 90.7%
EBIT
73.2% | 70.9%
Net Income
99.5% | 187.0%
Free Cash Flow
192.5%
Margin (TTM | estimate)
Gross
53.2%
EBITDA
- | 38.0%
EBIT
22.7%
Net
13.8% | 20.7%
Free Cash Flow
13.9%
Financial Health
Equity Ratio
73.6%
Return on Equity
2.7%
ROCE
6.1%
ROIC
4.6%
Debt/Equity
0.3
More
EPS
DKK9.1
FCF per Share
DKK9.1
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Novonesis a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Novonesis Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Novonesis forecast:

17x Buy
74%
4x Hold
17%
2x Sell
9%

Analyst Opinions

23 Analysts have issued a Novonesis forecast:

Buy
74%
Hold
17%
Sell
9%

Financial data from Novonesis

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
30,587 30,587
35% 35%
100%
- Direct Costs 14,306 14,306
18% 18%
47%
16,281 16,281
53% 53%
53%
- Selling and Administrative Expenses 6,259 6,259
46% 46%
20%
- Research and Development Expense 3,251 3,251
33% 33%
11%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 6,949 6,949
73% 73%
23%
Net Profit 4,215 4,215
100% 100%
14%

In millions DKK.

Don't miss a Thing! We will send you all news about Novonesis directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.

Head office Denmark
CEO Ester Baiget
Website www.novozymes.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today